本页面由Tiger Trade Technology Pte. Ltd.提供服务

Mirum Pharmaceuticals, Inc.

91.66
-4.8900-5.06%
盘后92.030.3700+0.40%19:26 EDT
成交量:119.44万
成交额:1.10亿
市值:55.31亿
市盈率:-195.02
高:96.58
开:95.15
低:90.91
收:96.55
52周最高:109.28
52周最低:36.88
股本:6,034.16万
流通股本:3,998.57万
量比:1.56
换手率:2.99%
股息:- -
股息率:- -
每股收益(TTM):-0.4700
每股收益(LYR):-0.4700
净资产收益率:-8.65%
总资产收益率:-1.83%
市净率:17.58
市盈率(LYR):-195.02

数据加载中...

2026/03/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/25

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/02/25

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/25

重要事件披露

Form 8-K - Current report
2026/02/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/26

重要事件披露

Form 8-K - Current report
2026/01/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/12

重要事件披露

Form 8-K - Current report